Lineage Cell Therapeutics Inc (LCTX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 03-2021 | 12-2020 | 09-2020 | 06-2020 | 03-2020 | |
| Sales | 391 | 355 | 571 | 386 | 514 |
| Cost of Goods | 112 | 114 | 102 | 75 | 94 |
| Gross Profit | 279 | 241 | 469 | 311 | 420 |
| Operating Expenses | 7,441 | 6,237 | 7,296 | 6,788 | 7,952 |
| Operating Income | -7,050 | -5,882 | -6,725 | -6,402 | -7,438 |
| Interest Expense | 2 | 0 | 0 | 0 | 0 |
| Other Income | 5,604 | 6,866 | -1,225 | -128 | -990 |
| Pre-tax Income | -1,448 | 984 | -7,950 | -6,530 | -8,428 |
| Income Tax | 0 | -1,061 | -178 | N/A | N/A |
| Net Income Continuous | -1,448 | 2,045 | -7,772 | -6,530 | -8,428 |
| Minority Interests | -32 | 13 | -12 | -8 | -29 |
| Net Income | $-1,416 | $2,032 | $-7,760 | $-6,522 | $-8,399 |
| EPS Basic Total Ops | -0.01 | 0.01 | -0.05 | -0.04 | -0.06 |
| EPS Basic Continuous Ops | -0.01 | 0.01 | -0.05 | -0.04 | -0.06 |
| EPS Diluted Total Ops | -0.01 | 0.01 | -0.05 | -0.04 | -0.06 |
| EPS Diluted Continuous Ops | -0.01 | 0.01 | -0.05 | -0.04 | -0.06 |
| EBITDA(a) | $-6,754 | $-5,521 | $-6,447 | $-5,849 | $-6,719 |